Category: <span>Treatment</span>

CARD Clinic in Libby Designated as Center of Excellence   

Lawmakers in Montana have declared the Center for Asbestos Related Diseases, also known as the CARD Clinic, as a Center of Excellence. The Montana House of Representatives passed a resolution in May 2023 recognizing the clinic’s importance. Lawmakers say the clinic based in Libby, Montana, played a significant role in an asbestos contamination Superfund that […]

The post CARD Clinic in Libby Designated as Center of Excellence    appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Netherlands Cancer Institute Tests New Mesothelioma Therapy

Research for a new type of mesothelioma treatment is underway at the Netherlands Cancer Institute. Scientists are exploring a novel combination of existing medications for patients with BAP1 genetic mutations.  More than half of all mesothelioma patients show alterations in the BAP1 tumor-suppressor gene. An altered BAP1 gene allows for vulnerabilities that make specific treatments […]

The post Netherlands Cancer Institute Tests New Mesothelioma Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma Treatment Uses Natural Immune Cells

For patients with mesothelioma cancer, immunotherapy is a promising new field. Results from a recent study at Rice University in Houston are exciting. Researchers are looking at ways the natural immune system can help fight this cancer.   The study examined the therapeutic effects of interleukin 2, a form of immunotherapy for mesothelioma. IL2 is a […]

The post Mesothelioma Treatment Uses Natural Immune Cells appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study Shows Opdivo, Yervoy Effective After Mesothelioma Surgery

Patients with recurrent mesothelioma cancer often have few options. A new study by the Hyogo College of Medicine in Japan may have a potential answer.  This study tested the safety and efficacy of two drugs following mesothelioma surgery after cancer recurrence. The combination of immunotherapy drugs nivolumab and ipilimumab, known by the brand names Opdivo […]

The post Study Shows Opdivo, Yervoy Effective After Mesothelioma Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival

Select patients diagnosed with mesothelioma cancer in both the thoracic and abdominal cavities still can achieve an extended survival if their treatment center performs the preferred types of aggressive surgery, according to a recent study at Baylor College of Medicine in Houston. Patients undergoing bicavitary cytoreductive surgery that includes the lung-sparing, extended pleurectomy and decortication […]

The post Baylor Study: Mesothelioma ‘Staged Surgical Approach’ Increases Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Looking Beyond Clinical Trials for Mesothelioma Treatment

Clinical trial results should not always be the guiding force when a mesothelioma cancer patient and their medical team determine what therapy path to take, according to one recent study. A look at real-world populations might be just as important. A research team at the University of Pennsylvania Department of Medicine has made the point […]

The post Looking Beyond Clinical Trials for Mesothelioma Treatment appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Kaiser Study Shows Benefits of Mesothelioma Specialty Centers

Patients diagnosed with pleural mesothelioma are better managed and survive longer when treated at an integrated specialty center, according to a study by Kaiser Permanente that compared its own performance before and after making the transition to specialty care. Doctors at the Kaiser Permanente Northern California health care system found a dramatic improvement once more […]

The post Kaiser Study Shows Benefits of Mesothelioma Specialty Centers appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study: ‘Drug-Factory’ Technology Kills Mesothelioma Tumor Cells in Mice

Tiny, drug-producing beads implanted in the chest cavity could one day provide a powerful platform that would change the way mesothelioma cancer is treated. In a recent study, researchers from Rice University and the Baylor College of Medicine demonstrated the implants’ impressive effectiveness in mice, raising hopes of a possible breakthrough for this tough-to-treat cancer. […]

The post Study: ‘Drug-Factory’ Technology Kills Mesothelioma Tumor Cells in Mice appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Specialty Centers Treating Mesothelioma Lead Best Hospitals Rankings

Mesothelioma specialty programs played a significant role in determining the latest U.S. News & World Report Best Hospitals for Cancer Care annual rankings. For the eighth consecutive year, MD Anderson Cancer Center in Houston was ranked No. 1, followed by Memorial Sloan Kettering in New York; Mayo Clinic in Rochester, Minnesota; Dana Farber/Brigham and Women’s […]

The post Specialty Centers Treating Mesothelioma Lead Best Hospitals Rankings appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma

Patients with unresectable pleural mesothelioma cancer throughout the United Kingdom will now have the immunotherapy combination of Opdivo and Yervoy as an option after its recent approval by the National Health Service for first-line treatment. The long-awaited approval comes almost two years after the U.S. Food and Drug Administration granted a similar approval of Opdivo […]

The post UK Approves Opdivo/Yervoy Immunotherapy for Pleural Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

MARF to Host International Symposium on Malignant Mesothelioma

Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in Chicago. This is an event well worth attending. The day-long symposium will be held at Summit Chicago, a welcoming venue where a wide range of mesothelioma experts will be speaking on […]

The post MARF to Host International Symposium on Malignant Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival

Patients with pleural mesothelioma undergoing aggressive surgery should consider combining it with controversial hyperthermic intrathoracic chemotherapy to extend survival, according to a recent study. Although the procedure, also known as HITHOC, has yet to be proven effective in a randomized clinical trial – and still is being debated by mesothelioma specialists – the report has […]

The post Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Peritoneal Mesothelioma HIPEC Program Comes to Alabama

Patients in Alabama diagnosed with peritoneal mesothelioma cancer no longer need to leave the state in pursuit of optimal care and long-term survival. The best possible mesothelioma treatment is now closer to home. The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham recently launched a complex treatment program for several abdominal malignancies […]

The post Peritoneal Mesothelioma HIPEC Program Comes to Alabama appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Despite Intense Political Debate, Mesothelioma Advocates Strongly Support Obamacare

While considerable debate is battled in Congress over the worth of the Affordable Care Act, known as Obamacare, cancer advocates strongly support it.